Moderna Inc
NASDAQ:MRNA 4:00:00 PM EDT
Products, Regulatory
Moderna Announces Amendment To Supply Agreement With The Ministry Of Health Of Israel To Supply Additional Doses Of mRNA Vaccine Against Covid-19
Published: 12/04/2020 13:39 GMT
Moderna Inc (MRNA) - Moderna Announces Amendment to Supply Agreement With the Ministry of Health of Israel to Supply Additional Doses of Mrna Vaccine Against Covid-19 (mrna-1273).
Moderna Inc - Israeli Government Has Now Secured 6 Million Doses of Mrna-1273.
Moderna Inc - Expanded Supply Agreement With Ministry of Health of Israel for an Additional 4 Million Doses of Mrna-1273.
Moderna - Working With Its Strategic Manufacturing Partners, Lonza of Switzerland and Rovi of Spain, for Manufacturing and Fill-finish Outside of U.S.moderna Inc - Has Already Initiated Rolling Regulatory Review Process With Ministry of Health in Israel.
Moderna Inc - Continues to Scale Up Its Global Manufacturing to Be Able to Deliver Approximately 500 Million Doses per Year.
Moderna Inc - Continues to Scale Up Its Global Manufacturing to Be Able to Deliver Possibly Up to 1 Billion Doses per Year, Beginning in 2021.
Moderna Inc - Israeli Government Has Now Secured 6 Million Doses of Mrna-1273.
Moderna Inc - Expanded Supply Agreement With Ministry of Health of Israel for an Additional 4 Million Doses of Mrna-1273.
Moderna - Working With Its Strategic Manufacturing Partners, Lonza of Switzerland and Rovi of Spain, for Manufacturing and Fill-finish Outside of U.S.moderna Inc - Has Already Initiated Rolling Regulatory Review Process With Ministry of Health in Israel.
Moderna Inc - Continues to Scale Up Its Global Manufacturing to Be Able to Deliver Approximately 500 Million Doses per Year.
Moderna Inc - Continues to Scale Up Its Global Manufacturing to Be Able to Deliver Possibly Up to 1 Billion Doses per Year, Beginning in 2021.